| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |